skip to Main Content
Kaiser Permanente
Permanente Medicine
  • About us
  • Our work
  • The Permanente Federation
  • News
  • Search

Remdesivir

Home » Remdesivir

Permanente Medicine powers coordinated effort around remdesivir clinical research trials

  • May 21, 2020
Collaboration between Kaiser Permanente’s care delivery system and research programs has driven the successful implementation of remdesivir clinical trials across regions.
Read More→

Initial COVID-19 drug trials ‘give us hope,’ Stephen Parodi, MD, tells CBSN

  • May 11, 2020
Stephen Parodi, MD, associate executive director of The Permanente Medical Group and national infectious disease leader for Kaiser Permanente, spoke with CBSN recently about why trials with remdesivir and other drugs matter. CBSN is the CBS News 24/7 digital streaming service.
Read More→

Kaiser Permanente research centers prioritize urgent COVID-19 research projects, clinical trials

  • May 2, 2020
In an effort to improve understanding and clinical practice guidelines around the novel coronavirus, Kaiser Permanente’s various research centers are quickly moving to investigate potential treatment for COVID-19.
Read More→
  • Physician profiles
  • Excellence in specialty care
  • Physician leadership
  • Leading in quality
  • Innovation
  • Research
  • Kaiser Permanente School of Medicine
  • Permanente Medicine podcast
Permanente Medical Groups

Colorado Permanente Medical Group

Hawaii Permanente Medical Group

Mid-Atlantic Permanente Medical Group

Northwest Permanente

The Permanente Medical Group (Northern California)

The Southeast Permanente Medical Group

Southern California Permanente Medical Group

Washington Permanente Medical Group

Quick links

About Kaiser Permanente

Center for Total Health

Care Management Institute

Physician Careers

Permanente Medicine Brand Store

Contact us

Legal

Privacy Policy

Terms & Conditions

Exceptional Care Experience. All rights reserved.
Website produced by Multimedia Communications

Back To Top
×

Don’t miss out on stories from our website!

Opt in to receive our newsletter.


Close